# A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD

> **NCT00242333** · PHASE2 · COMPLETED · sponsor: **Sosei** · enrollment: 300 (—)

## Conditions studied

- COPD

## Interventions

- **DRUG:** AD 237

## Key facts

- **NCT ID:** NCT00242333
- **Lead sponsor:** Sosei
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 300 (—)
- **Last updated:** 2006-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242333, "A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00242333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*